Fingerprint
Dive into the research topics of 'Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma
D. A. Van Echo, S. Markus, J. Aisner, P. H. Wiernik
Research output: Contribution to journal › Article › peer-review